British Journal of Dermatology

Article	Citations
银屑病皮肤细胞中的小分子 RNA 促进炎症发生	242
Correction	237
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing	156
Atypical melanocytes of an atypical Spitz tumour observed with optical super-high magnification dermoscopy	103
Delusional infestation – do not be scared!	101
How to score the impact of treatment on cutaneous neurofibromas in clinical trials	101
O11 The human discs large protein (Dlg1) controls connexin 43 (Cx43) plasma membrane localization and gap junctional communication in keratinocytes	89
O06 Exploring host–microbiome–immune interactions using singular and multispecies inoculations in optimized 3D skin models	86
Interactive effect of genetic and environmental risk factors on psoriasis: current evidence and future directives	78
Editor's Choice – John Ingram – Sep 2023	77
Issue Information	76
Higher proportion of cellulitis in severe lymphoedema	74
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin	73
Greater understanding about differences in the long-term course of eczema and their risk factors in children	73
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial	71
A guide to using the core outcome set for eczema	70
A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus	70
Editor's Choice – John Ingram – December 2023	69
O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways	66
Risankizumab versus apremilast in the era of skin clearance	66
Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review	64
Proliferative actinic keratoses are associated with adverse clinical outcomes relative to actinic keratoses without a proliferative growth pattern	60
Newborn genome screening (the Generation Study): the advent of presymptomatic diagnosis for genodermatoses	59
010 Enhanced outcome prediction in cutaneous squamous cell carcinoma using deep-learning and computational histopathology (cSCCnet)	57
CD03 Contact sensitization to shellac: a possible marker of fragrance allergy	57

P13 A rare case of Sjögren syndrome in a White woman with Kikuchi–Fujimoto disease	56
P50 Exploring unmet needs and attitudes to skin self-examination in melanoma survivors: EUNASS study	56
DP22 Cutaneous lymphoid hyperplasia: clinicopathological correlation and a therapeutic option	55
PA37 A retrospective review of the impact of virtual reality headsets in paediatric skin surgery	53
SG10 (P058) The epidemiology of epidermolysis bullosa in England, 1997–2024: a retrospective national cohort study	52
730 - Patient opinions on healthcare provider interactions and current treatment satisfaction in adults with atopic dermatitis by race and ethnicity	51
P74 Guselkumab clinical super-response is associated with faster normalization of blood and skin pathology: data from the Phase 3b GUIDE trial	51
CPC02 Delayed widespread lichenoid drug reaction with radioisotopic response in a patient treated with nivolumab	51
P67 Overall lifetime risk for alopecia areata is 2.1% and is higher in women, non-White ethnic groups and the most deprived: a UK population-based cohort study	51
P068 Oral tofacitinib in comparison with dexamethasone oral mini-pulse therapy for the treatment of active nonsegmental vitiligo: a randomized controlled trial	51
PA24 Abnormal interferon signature in a patient with chilblain lupus	50
BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report	50
603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial	47
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment	46
DP21 Thymoma and the skin: manifestations of multiorgan autoimmunity	46
BH18 A rare case of nail sarcoidosis presenting as an ulcerated nail tumour in a Afro-Caribbean patient	46
BI26 Treatment-induced scleroderma in a patient with metastatic melanoma	46
677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study	46
P19 The association between psoriatic disease severity and adherence to the Mediterranean diet: a systematic review of observational studies	45
691 - Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment	45
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review	45
673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials	45
P020 A rare phenomenon in a rare disease: reverse Koebner phenomenon in cutaneous Rosai–Dorfman disease	44
O02 Skin cancer service disparities across England: what data can tell us about skin cancer diagnosis, referral pathways and treatment received in different NHS trusts	44
P099 Spesolimab use in effective treatment of generalized pustular psoriasis: a case report	43
BT06 (P163) Implementation of a novel direct-to-patient inflammatory teledermatology service	43
P79 A multidisciplinary expert consensus on the assessment of and support for mental health in children and young people living with skin conditions	43
BT12 A comparison of outcomes and cost-effectiveness in a teledermatology vs. a standard face-to-face 2-week wait UK model	43
BH10 Nailing the diagnosis	42
641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis	42
005 Association between prescription drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a UK population-based study	41
H17 Traditional medicine: a warts-and-all tale	41
BI08 Defining the burden of mucocutaneous disease in organ transplant recipients living with HIV: the Mucocutaneous disorders in Organ Transplant recipients living with HIV study	41
H15 A treatment for leprosy developed on the edge of Europe: Vincent Barry (1908–1975)	41
BH09 Mycophenolate mofetil in the management of lichen planus pigmentosus in a woman with frontal fibrosing alopecia	40
H20 Sarcoptes scabiei: to solve the current crisis, hunt for clues in our past	40
Missing melanomas in England during the COVID-19 pandemic: 2485 fewer melanoma diagnoses in 2020 than in 2019	40
PA12 Fats and figures: how abnormal lipids unravel the truth	40
H19 Not only a finder of ‘solutions’: Max Jessner, Holocaust survivor and discoverer of Jessner–Kanof lymphocytic infiltrate	39
Poster presentationsPA10 Hidradenitis suppurativa and trisomy 21: a case series	39
BH13 Current wig prescribing practices and financial evaluation in a National Health Service foundation trust: lessons learnt and future challenges	39
H06 The changing face of skin disease in warfare: from World War I to modern times	39
DS24 Is surgery the best management for keratoacanthoma centrifugum marginatum?	38
Poster presentationsBT15 Ethical implications of artificial intelligence in dermatology: use-case analysis of skin cancer diagnostic smartphone apps	38
P093 Bespoke omalizumab prescribing in chronic spontaneous urticaria	37
DS23 Evaluation of American Joint Committee on Cancer and alternative tumour classification systems for primary penile squamous cell carcinoma	37
O05 Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR),	37
SG08 The phenotypic spectrum of MBTPS2 mutations: two illustrative cases	37
Uncovering the genetic architecture of hidradenitis suppurativa	36
Mainstreaming genetic testing in dermatology in the UK	36

519 - Efficacy of prolonged ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months	35
Can brepocitinib be formulated into an effective topical therapy to treat mild-to-moderate chronic plaque psoriasis?	35
P068 A history of mycosis fungoides: from Alibert to mogamulizumab	35
Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade	35
Clinical practices and educational interests of dermatologists in Caribbean countries	34
SG02 Transdermal testosterone improves lower-extremity ulceration in a young man with newly diagnosed Klinefelter syndrome (47 XXY)	34
Expanding the SLURP1 disease spectrum: from Mal de Meleda to palmoplantar keratoderma/progressive symmetric erythrokeratoderma	34
Pathways to progress: DUSP1-associated palmoplantar keratoderma in the era of precision dermatology	33
The future of patient-reported outcome measurement in hyperhidrosis lies in thoughtful, evidence-based implementation	33
O03 Rapid eczema trials: generating evidence that patients need	32
Sexual and gender minority inclusivity in hidradenitis suppurativa patient-reported outcome measures	32
Seeking new topical therapies in psoriasis	32
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey	32
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis	32
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study	32
O20 Microbial dysbiosis drives cutaneous wound senescence via the IL-1β pathway	31
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey	31
The role of clinicians in dermatology industry innovation: a qualitative study	31
From connective tissue builders to cellular architects: the journey of the skin fibroblast	31
Neutrophil infiltration in allergic contact dermatitis to nickel	30
High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa	30
Trichostasis spinulosa	30
O25 Compared to sun-protected skin, the circadian transcriptome in sun-exposed skin demonstrates dampened, phase-advanced rhythms with fewer cycling genes	30
The Venous Garland of Sahli	29
705 - Patient preferences for atopic dermatitis treatment profiles: results from a discrete choice experiment	29
Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants	29
Methotrexate and ciclosporin improve skin biomarkers in paediatric atopic dermatitis: results from the TREatment of severe Atopic eczema Trial	29
Occupational skin cancer: measurements of ultraviolet radiation exposure bring knowledge for prevention	29
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study	29
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study	29
Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma	29
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit	29
Efficacy and safety of pumecitinib 3% gel in treating mild-to-moderate atopic dermatitis: a multicentre randomized double-blind parallel placebo-controlled phase IIb clinical trial	29
Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma	29
352 Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial	29
Successful treatment of severe subcorneal pustular dermatosis with the 308-nm ultraviolet B excimer laser	29
An ontological analysis of a dataset of curated dermatological gene–disease associations (G2P-Skin)	28
Molecular-guided targeted therapy with tumour necrosis factor inhibitor for the treatment of refractory paraneoplastic pemphigus	28
Gain-of-function variant in NNT causes premature diffuse familial sebaceous hyperplasia	28
Multiharmonic imaging-based automated recognition of cutaneous T-cell lymphoma	28
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials	27
Localized miliaria crystallina on the hands of a paediatric patient	27
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles	27
UK trends in work-related contact dermatitis caused by nickel, chromium and cobalt	27
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study	26
DS17 Two cases of traumatic pseudoaneurysm of the superficial temporal artery	26
Severity assessment agreement in atopic dermatitis and association with short-term response: a patient–partner cohort	26
Mechanistic in vivo studies of secondary skin-to-skin peanut allergen transfer to determine the impact of hand washing in reducing the risk of cutaneous sensitization	26
‘Substantial clinical benefit’ and ‘substantial clinical worsening’ cutoff of Vitiligo Impact Scale (VIS)-22 change scores	26
LY14 Diagnostic challenges in cutaneous lymphomas: the importance of multisite biopsy and challenges with clonality interpretation	25
Can the effects of the COVID-19 pandemic provide insights into the impact of melanoma underdiagnosis and delayed care?	25
BT12 An audit of teledermatology vs. face-to-face dermatology review: follow-up rates and management outcomes at a tertiary centre	25
Generalized pityriasis rotunda	25
Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with ‘skyline’ basal cell layer (PENS)	25
PS50 Our mindful skin	24
P152 Baseline characteristics and treatment effectiveness of abrocitinib in moderate-to-severe atopic dermatitis: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR) cohort anal	23
PS02 Patient and healthcare professionals’ perspectives on pain management in hidradenitis suppurativa: a quantitative and qualitative study	23
PS37 Bridging dermatology and psychosomatic medicine in patients with chronic pruritus: screening for psychosomatic burden in a bidisciplinary setting	23
LY01 Quantitative and functional alterations of B cells in cutaneous T-cell lymphomas	23
GD07 Clinicodermoscopic and histopathological correlation in Hansen disease: a cross-sectional observational study from a South-East Asian tertiary care centre	23
Detection of Merkel cell polyomavirus large T-antigen in Spitz naevi: a multimodal study	23
PS53 Impact of acne vulgaris severity, postinflammatory hyperpigmentation and scarring on peer bullying, school functioning and body appreciation in adolescents: a case–control study	22
P023 Acquired reactive perforating collagenosis in the setting of newly diagnosed primary biliary cholangitis	22
PS59 Itch, psychological issues and life-quality impairment in adverse skin reactions due to antitumour therapy in comparison with atopic dermatitis and melanoma in a multicentre cross-sectional, obse	22
P221 Optimizing dermatology advice and guidance referrals: a quality improvement project to enhance triage and decision making	22
P133 Improvements in sleep among people with atopic dermatitis: a systematic review of randomized clinical trial evidence and outcomes for biologic treatments	22
BH16 Early-onset onychodysplasia with multisystem ectodermal features in a toddler: a diagnostic challenge	22
PA03 Chronic urticaria associated with systemic symptoms caused by tetrahydrocannabinol use in an adolescent	22
P013 Referral pathways and diagnostic approaches in chronic spontaneous urticaria: results from the REVEAL UK survey	22
SG09 Vulvovaginal involvement and sexual dysfunction in women with ichthyosis: a cross-sectional questionnaire study	22
BT06 Introduction of a medical photography hub to optimize phototriage of 2-week-wait referrals	21
O8 Ultraviolet radiation reshapes the metabolome of skin commensal bacteria, influencing aryl hydrocarbon receptor signalling and barrier function	21
Prurigo nodularis: disease burden, clinical features and approach to management	21
Efficacy and safety of pazopanib in patients in Japan with primary cutaneous angiosarcoma pretreated with paclitaxel: results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG16	21
Pruritic rash and diarrhoea in a man with chronic alcohol use disorder	21
AI03 Common law with divergent futures: a comparative analysis of medicolegal liability for artificial intelligence-discordant triage in Great Britain, Northern Ireland and the Republic of Ireland	21
Living with vulval lichen sclerosus: a qualitative interview study	21
Body site-specific associations between human skin microbiome composition and psychological wellbeing	21
BSV05 Vulval lichen simplex and markers of anaemia and vitamin D deficiency in an ethnically diverse population	21
N -acetylcysteine exerts senescence-selective antifibrotic effects in fibroblast from chronic wounds in recessive dystrophic epidermolysis bullosa	21

P21 ELF5 is required to prevent keratinocyte malignancy transformation in vitro	21
Eczema in inborn errors of immunity with atopy: frequency, timing, phenotypic clustering	21
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry	20
Correction to: Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded c	20
514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age	20
Genetic basis of a novel rare dominant form of palmoplantar keratoderma	20
Lived experiences of patients with hidradenitis suppurativa-related pain	20
Parent and child experiences of skin conditions and views on mindfulness-based support	20
Burden of atopic dermatitis in paediatric patients: an international cross-sectional study	20
The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme	20
Correction to: Comment on ‘Treatment of moderate-to-severe alopecia areata in preadolescent children with baricitinib’: authors’ reply	20
P17 Pseudomonas infection causing acute painful flexural exacerbation in a child with IFAP syndrome	20
Greater understanding about a rare inherited skin disorder from a study of NLRP1 in two sisters with different severity of disease	20
Direct inhibition precedes p38 mitogen activated protein kinase-mediated uncoupling in desmosomes to reduce desmoglein 3 adhesion by pemphigus autoantibodies	20
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging	20
Insights into Pathogenesis of Chronic Spontaneous Urticaria	20
A review of genetic hair disorders	20
Hidradenitis suppurativa: BJD state-of-the-art review series	20
Creating the Scale of Alopecia Areata Distress to measure a wide range of negative emotional, social and relationship disease consequences in adults	19
转移性黑色素瘤免疫治疗后患者恢复生活的经验	19
P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice	19
P33 Investigating the utility and exploring biological targets of micro-wound healing compounds in 2D and 3D skin models	19
A clinical trial in children and young people with severe eczema comparing methotrexate with ciclosporin	19
Patient experiences of living with vulval lichen sclerosus	19
Implementing evidence-based strategies to optimize the journey of patients with hidradenitis suppurativa	19
The antidiabetic medicine metformin has beneficial effects in hidradenitis suppurativa	19
Insights into the biological differences in hair follicles of men with androgenetic alopecia	19
P088 Physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOST	18
CPC07 Lines of evidence: unravelling a case of blaschkoid Darier disease	18
BI24 Cutaneous pseudolymphoma secondary to pembrolizumab	18
PD05 Chronic actinic dermatitis: a multicentre evaluation	18
309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest	18
P101 Janus kinase inhibitors in palmoplantar pustulosis: a systematic review and meta-analysis of comorbidity burden to inform a feasibility trial’s design (JAKPPPOT)	18
PD15 Ultraviolet overexposure in solar urticaria: beyond the rash	18
Editor's Choice – John Ingram – March 2024	18
DS15 Comparing the costs of monitoring vs. excision of an indeterminate naevus	18
DS28 In search of salivation? Management of parotid duct injury following Mohs micrographic surgery	18
DS13 (P141) Biodegradable temporizing matrix: a first for dermatological surgery and a valuable reconstructive adjunct	18
Focusing on antigen-specific T cells	18
DS05 Overtreatment of skin cancer: how can we ensure those treated for basal cell carcinoma receive more benefit than harm?	18
698 - Impact of amlitelimab (an anti-OX40 ligand antibody) on clinical outcome assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with moderate-to-severe at	18
BH16 Nail changes as indicators of systemic disease: a systematic review of correlations and diagnostic outcomes	18
PA32 Terra firma-forme dermatosis in siblings	18
343 Dupilumab efficacy on itch and skin lesions in adult patients with prurigo nodularis may be observed concurrently or independently over 24 weeks: results from two phase 3 trials	17
649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials	17
FC16 Blood mass cytometry reveals Type 1 cytokine expression in blood of patients with paradoxical eczema secondary to biologics for psoriasis	17
DS21 Patients’ experience with one-stop skin cancer clinics	17
P45 An analysis of infantile haemangioma referrals and comparison with the infantile haemangioma European task force’s ‘infantile haemangioma referral score’	17
P156 Neoadjuvant immunotherapy for advanced melanoma: a clinical audit of pathological response and toxicity	17
O11 A patchy prognosis: identification of prognostic factors associated with progression in early-stage mycosis fungoides and first-line treatment selection	17
326 Dupilumab: a comparison of infection rates across atopic dermatitis trials in adults, adolescents, children and infants	17
DP02 (P30) Declining staff numbers and increasing workload: is there a solution?	17
DE04 Large-scale virtual dermatology teaching for internal medical trainees across the UK	17
BH21 Segmented heterochromia with calibre change: an under-recognized sign of alopecia areata	17
BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata	17
P046 Investigating sexual side-effects in female patients on isotretinoin via routine screening questionnaires	17
BH03 Lipoedematous scalp occurring in two female siblings: further evidence of a genetic role?	17
P15 Progressive papulonodular eruption following COVID-19 infection: a rare diagnosis and review of the literature	17
P111 An AI-assisted similarity search engine for enhanced psoriasis case identification and patient engagement	17
DP22 A solitary neurofibroma masquerading as smooth muscle hamartoma: a clinicopathological challenge	17
P53 Incidence of merkel cell carcinoma in the Republic of Ireland (1994–2019)	17
428 Evaluating chronic pruritus prevalence, characteristics and effects on atopic dermatitis patients from a referral university hospital in São Paulo, Brazil: a cross-sectional study	17
BI30 Remission of a large plantar verruca vulgaris in an immunocompromised patient postincisional punch biopsy	16
Foreword	16
A study looking at a possible new drug, HB0017, for the treatment of psoriasis	16
From flare to freedom: a young woman’s guttate psoriasis journey	16
HX22 Shining a light on dermatology	16
703 - Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with moderate and/or more extensive atopic dermatitis: subgroup analysis from the TRuE-AD3 study	16
FC09 Clinical and immunomodulatory effects of mesenchymal stromal cells in multiple biologic-refractory psoriasis	16
Officers and Committee 2024–2025	16
Diverse approaches to the diagnosis and treatment of paediatric vitiligo: a survey of paediatric dermatologists	16
DE02 Honing in on clinician needs: a grassroots development of an educational resource for dermatologists	16
622 - Shifting the care paradigm for individuals with skin of color (SOC): a comprehensive review of care gaps and emerging initiatives in dermatology	16
Getting evidence into practice: C3 will see it through	15
Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study	15
The association between atopic dermatitis and acne: a retrospective Finnish nationwide registry study	15
Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study	15
On the potential beneficial effects of indoor tanning	15
Infectious disease among adults with allergic contact dermatitis: a propensity score-matched case–control study	15
Dermatitis cruris pustulosa et atrophicans	15
Promising results for treatment of severe chronic hand eczema with dupilumab	15
Progression of in situ and early invasive cutaneous squamous cell carcinomas concurrent with successful target tumour response to a programmed death-1 inhibitor	15
Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma	15
Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study	15
Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021	15
Nicotinamide for skin cancer chemoprevention in transplant recipients: a critically appraised topic	15
BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?	15
Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib	15
Strongyloides screening prior to dupilumab therapy in atopic dermatitis: a retrospective cohort study evaluating screening utility	14
BI20 A fatal case of disseminated cutaneous Mycobacterium chelonae infection in an immunocompromised patient	14
Head lice: evidence that resistance to physically acting treatments is developing	14
696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the p	14
Living with PTEN hamartoma tumour syndrome: Jenna’s story	14
FC26 The MEditerranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis (METRED-P) study: an interim analysis of the first UK-based diet intervention trial	14
Analysis of laser-generated plume concentration during in vivo laser hair reduction procedures in a tertiary referral laser dermatology unit	14